TrialAnnals of oncology : official journal of the European Society for Medical Oncology2017

A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study.

B J Monk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.